(Q41847034)

13 October 2017

title

Serum cholesterol reduction with tamoxifen (English)

1 reference

13 October 2017

1 reference

D V Schapira

1

1 reference

13 October 2017

N B Kumar

series ordinal

2

1 reference

13 October 2017

G H Lyman

series ordinal

3

1 reference

13 October 2017

language of work or name

English

0 references

publication date

1 November 1990

1 reference

Breast Cancer Research and Treatment

13 October 2017

published in

1 reference

13 October 2017

volume

17

1 reference

13 October 2017

issue

1

1 reference

13 October 2017

page(s)

3-7

1 reference

Tamoxifen, serum lipoproteins and cardiovascular risk

13 October 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01812678

Menopause and coronary heart disease. The Framingham Study

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01812678

Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancer. 'Nolvadex' Adjuvant Trial Organisation

21 January 2018

1 reference

12 December 2020

Cardiovascular and risk factor evaluation of healthy American adults. A statement for physicians by an Ad Hoc Committee appointed by the Steering Committee, American Heart Association

1 reference

12 December 2020

Adjuvant tamoxifen in primary breast cancer: influence on plasma lipids and antithrombin III levels

1 reference

12 December 2020

Effect of estradiol and antiestrogens on cholesterol biosynthesis in hormone-dependent and -independent breast cancer cell lines

1 reference

12 December 2020

Early menopause and the risk of myocardial infarction.

1 reference

12 December 2020

Consensus conference. Adjuvant chemotherapy for breast cancer

1 reference

12 December 2020

Current status of the cholesterol controversy

1 reference

12 December 2020

Adjuvant tamoxifen in the management of operable breast cancer: the Scottish Trial. Report from the Breast Cancer Trials Committee, Scottish Cancer Trials Office (MRC), Edinburgh

1 reference

12 December 2020

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors

1 reference

12 December 2020

Serum High-Density-Lipoprotein Cholesterol in Women Using Oral Contraceptives, Estrogens and Progestins

1 reference

12 December 2020

Effects of an antiestrogen on subfractions of HDL cholesterol during estrogen replacement therapy

1 reference

12 December 2020

Serum lipoproteins and proteins after breast cancer surgery and effects of tamoxifen

1 reference

12 December 2020

Coronary risk prediction in adults (the Framingham Heart Study)

1 reference

12 December 2020

Effect of tamoxifen on oestrogen binding, lipid and lipoprotein concentrations and blood clotting parameters in premenopausal women with breast pain

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01812678

1 reference

Dimensions Publication ID

13 October 2017

1014550266

0 references

1 reference